Leaders Free III: BioFreedom™ Clinical Trial
A trial with no phase registered on ClinicalTrials.gov. The registry status is completed. It enrolled 404 participants.
Also called NCT03118895
- Study
- In this atlas
Overview
- Design
- Interventional study; allocation not applicable; no masking; primary purpose treatment
- Phase
- Not applicable
- Enrolled
- 404 participants
- Registry
-
NCT03118895
-
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- France, Switzerland
- Registry status
- Completed
Technical summary
Registry record NCT03118895. Allocation not applicable; no masking; primary purpose treatment. Start 2017-11-08 (actual); primary completion 2019-09-05 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Leaders Free III: BioFreedom™ Clinical Trial
- Condition
- Cardiac Death
- Condition
- Myocardial Infarction
- Condition
- Stent Thrombosis
- Condition
- Bleeding
- Condition
- Mortality
- Intervention (Device)
- BioFreedom™ BA9™ drug-coated stent
- Lead sponsor
- Biosensors Europe SA
- Collaborator
- European Cardiovascular Research Center
Record details
- Record id
cardio:ct-nct03118895- Content hash
3d6c61d2e0adc310946edcb364de9b9555b9d16ca4849cc2439d8ac8f8181cb9